This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Tuesday, April 5, 2011
2011 EASL; Easy To Understand Summary of the investigational Hepatitis C drugs
The International Liver Congress™ 2011 by EASL (46th annual meeting)
No comments:
Post a Comment